Pancreatic Cancer Canada and IMD Health Global announce partnership to improve the quality of patient education Toronto – July 21, 2022 Pancreatic Cancer Canada is pleased to announce an important new partnership with IMD Health. IMD Health is the largest digital...
Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...
Recent Comments